Treatment
You might have a targeted cancer drug for one of the following reasons:
you have stage 3 or 4 lymphoma, which is positive for a specific protein
your treatment isn't working
your lymphoma has come back (relapsed Hodgkin lymphoma)
you have nodular lymphocyte predominant Hodgkin lymphoma (NLPHL). This is a rare type of Hodgkin lymphoma
Learn about the types of Hodgkin lymphoma
Some drugs work in more than one way. They are targeted and work with the immune system.
Monoclonal antibodies (MABs) are the most common type of targeted drug used for Hodgkin lymphoma.
Brentuximab and rituximab are a type of monoclonal antibody. They target specific proteins on lymphoma cells and help the immune system to find these cells and kill them. Because of the way they work they are sometimes called targeted immunotherapy drugs.
Read more about monoclonal antibodies
Brentuximab targets a protein called CD30, which is found on Hodgkin lymphoma cells. Brentuximab sticks to the CD30 protein and delivers a drug to the cell. The drug then kills the cell.
You might have brentuximab with chemotherapy if you have stage 3 or 4 Hodgkin lymphoma.
You could also have bentuximab if your treatment isn't working, or if it has come back. But you first need to have had one of the following:
a that hasn’t worked
two other treatments if you couldn’t have a stem cell transplant
Rituximab targets a protein called CD20, which is found on called B cells. This then flags the cells to the immune system, which picks out the cells and kills them.
You might have this as your first treatment if you have advanced stage NLPHL or relapsed NLPHL.
You usually have rituximab with chemotherapy. You might have it with a combination of chemotherapy drugs and a steroid, such as:
R-CHOP - rituximab, cyclophosphamide, doxorubicin, vincristine and prednisolone
R-ABVD - rituximab, doxorubicin, bleomycin, vinblastine and dacarbazine
R-CVP - rituximab, cyclophosphamide, vincristine and prednisolone
R-CVinbP - rituximab, cyclophosphamide, vinblastine and prednisolone
Pembrolizumab and nivolumab are types of immunotherapy. They stimulate the body’s immune system to fight cancer cells.
Pembrolizumab targets and blocks proteins called PD-1 on the surface of certain immune cells called T cells. Blocking PD-1 triggers the T cells to find and kill cancer cells.
You might have pembrolizumab if you:
have had at least 2 previous treatments
have already had brentuximab
can't have a stem cell transplant using your own cells
Nivolumab also blocks the PD-1 protein that stops the immune system from working properly and attacking cancer cells.
You might have nivolumab if either:
your previous treatment hasn’t worked very well
your lymphoma has come back
Before you have nivolumab you must have had both:
brentuximab
a stem cell transplant if you were able to have one
You usually have targeted and immunotherapy drugs through a drip into your arm. A nurse puts a small tube (a cannula) into one of your veins and connects the drip to it.
You may need a central line. This is a long plastic tube that gives the drugs into a large vein, either in your chest or through a vein in your arm. It stays in while you’re having treatment, which may be for a few months.
You might have rituximab as an injection under the skin. This is called a subcutaneous injection. You can only have rituximab as an injection if you’ve had at least one dose of rituximab into your bloodstream. And you didn’t have any serious side effects while you had it.
You might have a dull ache for a short time after this type of injection but it doesn’t usually hurt much. The skin in the area may go red and itchy for a while.
Everyone is different and the side effects vary from person to person. The side effects you may have depend on:
which cancer drug you have
whether you have it alone or with other cancer drugs
the amount of cancer drug you have (the dose)
your general health
A side effect may get better or worse during your treatment. Or more side effects may develop as the treatment goes on.
A common side effect of some monoclonal antibodies is an allergic reaction to the drug. This reaction is most likely to happen during your first treatment. Your nurse might give you medicines before treatment to prevent an allergic reaction.
Possible side effects for targeted and immunotherapy drugs include:
skin changes such as red and sore skin or an itchy rash
loose watery poo (diarrhoea)
tiredness
flu-like symptoms such as chills, fever or dizziness
feeling or being sick
Targeted and immunotherapy drugs can cause different side effects. Some of these can be serious. Your doctor or nurse will talk to you about this. Always tell them about any side effects you have and follow the advice they give you.
For more information about the side effects of your treatment, go to the individual drug pages.
You might have treatment as part of a clinical trial for Hodgkin lymphoma.
Researchers are looking at:
having immunotherapy or targeted cancer drugs as the first treatment for Hodgkin lymphoma
new targeted and immunotherapy drugs
different combinations of these cancer drugs with other treatments
Find a clinical trial looking at the treatment of Hodgkin lymphoma
Treatment with immunotherapy or targeted cancer drugs can be difficult to cope with for some people. Your nurse will give you a number to call (advice line) if you have any problems at home.
Last reviewed: 02 Jul 2024
Next review due: 02 Jul 2027
The main treatments for Hodgkin lymphoma include chemotherapy and radiotherapy. The treatment you have depends on a number of things such as the type and stage of Hodgkin lymphoma and your general health.
Get practical and emotional support to help you cope with a diagnosis of Hodgkin lymphoma, and life during and after treatment.
Hodgkin lymphoma treatment is usually very successful and most people are cured. The treatment you have depends on the type and stage of your Hodgkin lymphoma, as well as your general health. You might have more than one treatment.
Read about chemotherapy and the drugs used to treat Hodgkin lymphoma.
All cancer treatments must be fully researched before they can be used for everyone. This is so we know that they work, are better than the treatments already available, and are safe. Current research is looking at ways to improve the diagnosis and treatment of Hodgkin lymphoma.
Hodgkin lymphoma is a cancer of a type of white blood cell called lymphocytes. Find out more about the tests, treatments and support available if you have Hodgkin lymphoma.

About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education
Search our clinical trials database for all cancer trials and studies recruiting in the UK.
Meet and chat to other cancer people affected by cancer.
Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.